Evidence map›Paper›PMID 41728073›Full record

ArticleBiomaterials research2026

Construction of Rough Surfaces Based on Zirconium Metal-Organic Frameworks to Enhance Photothermal and Photodynamic Therapy for Multiple Myeloma.

Mengyu Xu, Lihua Ma, Min Liu, Yuanxin Chen, Xianjun Wang, Lijuan Wang, Yanxi Zhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomaterials research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mengyu XuCentral Laboratory, Linyi People's Hospital, School of Clinical Medicine, Shandong Second Medical University, Shandong, China.
Lihua MaCentral Laboratory, Linyi People's Hospital, School of Clinical Medicine, Shandong Second Medical University, Shandong, China.
Min LiuPostgraduate Training Base of Linyi People's Hospital, Guangzhou University of Chinese Medicine, Linyi, China.
Yuanxin ChenLinyi Key Laboratory of Tumor Biology, Linyi, Shandong, China.
Xianjun WangDepartment of Neurology, Linyi People's Hospital, Linyi, Shandong, China.
Lijuan WangCentral Laboratory, Linyi People's Hospital, School of Clinical Medicine, Shandong Second Medical University, Shandong, China.
Yanxi ZhuCentral Laboratory, Linyi People's Hospital, School of Clinical Medicine, Shandong Second Medical University, Shandong, China.ORCID https://orcid.org/0000-0002-7172-4087

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotargeted drug delivery systems (nanotargeted DDS) have emerged as promising solutions to improve treatment precision and reduce toxicity. However, achieving efficient delivery from the bloodstream to the tumor site remains challenging due to the complex tumor microenvironment (TME). To address these issues, a novel pH-responsive surface-switching DDS, UiO@CeO

Identifiers

PMID41728073
PMCPMC12921127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.